The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 16, 2024

Filed:

Mar. 14, 2022
Applicants:

Institut Pasteur, Paris, FR;

Universidad El Bosque, Bogota, CO;

Inventors:

Claude Roth, Paris, FR;

Etienne Simon-Loriere, Paris, FR;

Anavaj Sakuntabhai, Paris, FR;

Felix Delgado, Bogota, CO;

Assignees:

INSTITUT PASTEUR, Paris, FR;

UNIVERSIDAD EL BOSQUE, Bogota, CO;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 9/00 (2006.01); A61K 39/12 (2006.01); A61K 39/295 (2006.01); A61P 31/14 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 9/0029 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 2770/24122 (2013.01); C12N 2770/24134 (2013.01);
Abstract

The present invention is directed to a Zika virus (ZIKV) chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition. The present invention provides means, in particular polynucleotides, vectors and cells expressing said chimeric polyepitope. The present invention also relates to a composition or a vaccine comprising at least one of said polyepitope, polynucleotide, vector or host cell for use in the prevention of a ZIKV infection in a human subject, or for use in the prevention of ZIKV and dengue virus (DENV) infections in a human subject.


Find Patent Forward Citations

Loading…